Psychiatric Times Vol 14 No 9

Psychiatric Consultant's Role Continues to Grow at Life Insurance Company

September 01, 1997

I find expertise is best defined by the attending psychiatrist. I usually ask them whose opinion they respect in the community, whether that person is acceptable to them to do the evaluation and if their conclusions about disability would be acceptable. If the attendings have no one in mind, I have developed a network of excellent forensic psychiatrists around the country from which I can draw. In this case, I make a suggestion, and ask the attending if the particular provider is acceptable.

The Psychiatrist as Novelist: A Discussion with Keith Ablow

September 01, 1997

My best advice is that whatever you're going to branch out into, it's like Abraham Lincoln said: 'If I had nine hours to chop down a tree, I'd spend eight sharpening my axe.' If you really want to write a novel and use your psychiatric expertise to do that, first really dedicate yourself to learning the structure of a novel. Even if it's something as simple as buying a series of tapes, taking a class or buying a book. Do that before you put pen to paper. And then, actually do the work.

Specializing in Sex Therapy

September 01, 1997

There's such an enormous need, said Renshaw, noting that a study of 100 white, middle-class, well-educated couples revealed that more than 70% of the women and 50% of the men reported they had sexual problems. "Ours is a small clinic, in no way able to meet the demand for treatment or training from all who request it. About 80 couples a year are treated. The waiting list is much too long. Couples wait between three and 10 months to come in for therapy, a far from ideal situation."

Sales of Generic Drug Blocked by Injunction

September 01, 1997

An injunction barring further marketing of the generic drug Repronex, recently approved by the Food and Drug Administration, was issued by a U.S. District Court July 25. Although this is the first time that a court has ruled against an FDA determination of generic equivalence in numerous lawsuits brought by manufacturers of reference brand products, it is not the first time that Sporkin has decided against a federal agency. Sporkin wrote, "the FDA cannot selectively choose to reinterpret the FFDCA (Federal Food Drug and Cosmetic Act) and its own implementing regulations in such an arbitrary manner. 'Same' means 'identical,' just as the agency's own regulation say and an agency must follow its own regulations and not arbitrarily reinterpret those regulations."